The effects of oral supplementation of ascorbic acid (1500 mg d-1) on urinary β-glucuronidase (β-G) activity was assessed in a double-blind crossover study design over a 3-week period. The subjects on ascorbic acid treatment displayed a statistically significant (P < 0.05) decrease in β-G with an approximate decrease of 25%.
Get full access to this article
View all access options for this article.
References
1.
Sporn MBVitamin A and its analogs (retinoids) in cancer prevention. In: Nutrition and Cancer, ed. M Winick.New York: Wiley-Interscience , 1977 .
2.
Kerr WK, Barkin M., Levers PW & Menczyk Z.The effect of cigarette smoking on bladder carcinogenesis in man. Journal of the Association of Medicine (Canada) 1965 ; 93.
3.
Jackson CD & Baetcke KPCausative agents in the induction of bladder cancer. Annals of Clinical Laboratory Science1976; 6:223.
4.
Case Ram.The mortality from cancer in the urinary bladder in England and Wales . In: Tumours of the Bladder ed. DM Wallace.London: Livingstone , 1959.
5.
Adamson RH & Davies DSComparative aspects of absorption, distribution, metabolism and excretion of drugs. In: Comparative Pharmacology, Vol. 2, ed. MH Michèlson, p. 851. New York : Pergamon Press, 1973.
6.
Dutton GJGlucuronidation of drugs and other compounds. Boca Raton, Florida: CRC Press Inc., 1980.
7.
Boyland E., Kinder CH, Manson D. & Wallace DMAn attempt to prevent the induction of bladder cancer in dogs with 1-4-glucosaccharolactone . Investigative Urology1965; 2:439.
8.
Miyakawa M., Yoshida O., Haroda T. & Kato T.The effect of urinary β-glucuronidase inhibitor on the induction of bladder tumours with 2-acetylaminofluorene in rats. Investigative Urology1973; 10:256.
9.
Ichikawa T. & the Japanese Research Group of Bladder Carcinoma.Clinical application of 2,5-di-O-acetyl-β-D-glucaro- (1-4) (6-3)-dilactone (SLA) to the bladder tumour with special reference to its effect on frequency to tumour recurrences. Journal of Urology1972; 108:571.
10.
Becker B. & Friedenwald JSThe inhibition of glucuronidase by ascorbic acid and by heparin. Archives of Biochemistry1949; 22:101.
11.
Mills GT, Paul J. & Smith Eeb.Studies on β-glucuronidase. 2. The preparation and properties of three ox-spleen β-glucuronidase fraction. Biochemical Journal1953; 53: 232.
12.
Levvy GA & Marsh CAThe effects of heavy metal ions on mammalian β-glucuronidase. Biochemical Journal1957; 53:232.
13.
Brown BWThe crossover experiment for clinical trials. Biometrics1980; 36:69.
14.
Schlegel JEProposed uses of ascorbic acid in prevention of bladder carcinoma. Annals of the New York Academy of Science1975; 258:432.
